WHO / CERVICAL CANCER
17-Nov-2021
00:03:53
The World Health Organization (WHO) commemorated a Day of Action for Cervical Cancer Elimination and welcomed groundbreaking new initiatives to end the devastating disease, which claims the lives of over 300,000 women each year. WHO
Subject to the Terms of Usages of UNifeed, UNifeed materials are available free of charge for news purposes only. UNifeed materials may not be sold or redistributed to third parties without the prior written consent of the UN or the UN entity which is source of the UNifeed material. All users of UNifeed materials must provide due credit to the United Nations or any UN entity source(s) in their use and broadcast of UNifeed materials.
Size
Format
Acquire
DESCRIPTION
STORY: WHO / CERVICAL CANCER
TRT: 3:53
SOURCE: WHO
RESTRICTIONS: NONE
LANGUAGE: ENGLISH / NATS
DATELINE: 17 NOVEMBER 2021, GENEVA, SWITZERLAND
TRT: 3:53
SOURCE: WHO
RESTRICTIONS: NONE
LANGUAGE: ENGLISH / NATS
DATELINE: 17 NOVEMBER 2021, GENEVA, SWITZERLAND
SHOTLIST
FILE – NEW YORK CITY
1. Wide shot, WHO emblem outside headquarters
17 NOVEMBER 2021, GENEVA, SWITZERLAND
2. Wide shot, press room
3. SOUNDBITE (English) Dr Tedros Adhanom Ghebreyesus, Director-General, World Health Organization (WHO):
"Cervical cancer is the fourth most common cancer among women globally, but it is almost completely preventable and, if diagnosed early enough, is one of the most successfully treatable cancers. This disease claims the lives of 300,000 women each year – 1 every 2 minutes. Like COVID-19, we have the tools to prevent, detect, and treat this disease. But like COVID-19, cervical cancer is driven by inequitable access to those tools. 79 countries that account for two-thirds of the global burden of cervical cancer are yet to introduce HPV vaccines, because of high prices and inadequate supply."
4. Wide shot, press room
5. SOUNDBITE (English) Dr Tedros Adhanom Ghebreyesus, Director-General, World Health Organization (WHO):
"In low- and middle-income countries, the incidence of cervical cancer is nearly twice as high, and the death rate is three times as high, as in high-income countries. We see similar disparities among marginalized populations within many high-income countries. That’s why one year ago today, WHO launched a global strategy to eliminate cervical cancer, with three targets to achieve within the next 10 years: To vaccinate 90 percent of all girls against human papillomavirus by the age of 15; to expand access to screening services for 70 percent of women; and to expand access to treatment for 90 percent of women with pre-cancerous lesions, and palliative care for 90 percent of women with invasive cancer."
6. Wide shot, press room
7. SOUNDBITE (English) Dr Tedros Adhanom Ghebreyesus, Director-General, World Health Organization (WHO):
"Like it has with so many diseases, the pandemic has caused setbacks to progress towards these targets because of disruption to health services. The proportion of girls globally with access to HPV vaccines has fallen to 13 percent, from 15 percent before the pandemic. At the same time, there are encouraging signs of progress. In the past year, several more countries have introduced the HPV vaccine into national immunization schedules, including Cameroon, Cabo Verde, El Salvador, Mauritania, Qatar, Sao Tome and Principe, and Tuvalu. WHO has also prequalified a fourth HPV vaccine called Cecolin, produced by Innovax, which we expect will increase supply and decrease prices. We have also seen innovations like self-sampling, which offers women the option of being screened for cervical cancer without a pelvic exam."
8. Wide shot, press room
9. SOUNDBITE (English) Dr Tedros Adhanom Ghebreyesus, Director-General, World Health Organization (WHO):
"Today we are releasing WHO’s evidence generation framework for artificial intelligence-based screening. But we need to do much more. Today we are calling on all countries, all manufacturers of vaccines, tests and treatments, all partners and all civil society organizations to join us in our effort to make cervical cancer history."
10. Wide shot, WHO emblem on wall in press room
1. Wide shot, WHO emblem outside headquarters
17 NOVEMBER 2021, GENEVA, SWITZERLAND
2. Wide shot, press room
3. SOUNDBITE (English) Dr Tedros Adhanom Ghebreyesus, Director-General, World Health Organization (WHO):
"Cervical cancer is the fourth most common cancer among women globally, but it is almost completely preventable and, if diagnosed early enough, is one of the most successfully treatable cancers. This disease claims the lives of 300,000 women each year – 1 every 2 minutes. Like COVID-19, we have the tools to prevent, detect, and treat this disease. But like COVID-19, cervical cancer is driven by inequitable access to those tools. 79 countries that account for two-thirds of the global burden of cervical cancer are yet to introduce HPV vaccines, because of high prices and inadequate supply."
4. Wide shot, press room
5. SOUNDBITE (English) Dr Tedros Adhanom Ghebreyesus, Director-General, World Health Organization (WHO):
"In low- and middle-income countries, the incidence of cervical cancer is nearly twice as high, and the death rate is three times as high, as in high-income countries. We see similar disparities among marginalized populations within many high-income countries. That’s why one year ago today, WHO launched a global strategy to eliminate cervical cancer, with three targets to achieve within the next 10 years: To vaccinate 90 percent of all girls against human papillomavirus by the age of 15; to expand access to screening services for 70 percent of women; and to expand access to treatment for 90 percent of women with pre-cancerous lesions, and palliative care for 90 percent of women with invasive cancer."
6. Wide shot, press room
7. SOUNDBITE (English) Dr Tedros Adhanom Ghebreyesus, Director-General, World Health Organization (WHO):
"Like it has with so many diseases, the pandemic has caused setbacks to progress towards these targets because of disruption to health services. The proportion of girls globally with access to HPV vaccines has fallen to 13 percent, from 15 percent before the pandemic. At the same time, there are encouraging signs of progress. In the past year, several more countries have introduced the HPV vaccine into national immunization schedules, including Cameroon, Cabo Verde, El Salvador, Mauritania, Qatar, Sao Tome and Principe, and Tuvalu. WHO has also prequalified a fourth HPV vaccine called Cecolin, produced by Innovax, which we expect will increase supply and decrease prices. We have also seen innovations like self-sampling, which offers women the option of being screened for cervical cancer without a pelvic exam."
8. Wide shot, press room
9. SOUNDBITE (English) Dr Tedros Adhanom Ghebreyesus, Director-General, World Health Organization (WHO):
"Today we are releasing WHO’s evidence generation framework for artificial intelligence-based screening. But we need to do much more. Today we are calling on all countries, all manufacturers of vaccines, tests and treatments, all partners and all civil society organizations to join us in our effort to make cervical cancer history."
10. Wide shot, WHO emblem on wall in press room
STORYLINE
The World Health Organization (WHO) commemorated a Day of Action for Cervical Cancer Elimination and welcomed groundbreaking new initiatives to end the devastating disease, which claims the lives of over 300,000 women each year.
Speaking at a press conference in Geneva today (17 Nov), WHO chief Dr Tedros Ghebreyesus said cervical cancer is the fourth most common cancer among women globally, “but it is almost completely preventable and, if diagnosed early enough, is one of the most successfully treatable cancers.” He said the disease claims the lives a woman every two minutes. He added, “Like COVID-19, we have the tools to prevent, detect, and treat this disease. But like COVID-19, cervical cancer is driven by inequitable access to those tools. 79 countries that account for two-thirds of the global burden of cervical cancer are yet to introduce HPV vaccines, because of high prices and inadequate supply."
Dr Tedros said, in low- and middle-income countries, the incidence of cervical cancer “is nearly twice as high, and the death rate is three times as high, as in high-income countries.” He said there are similar disparities among marginalized populations within many high-income countries.
A year ago today, WHO had launched a global strategy to eliminate cervical cancer, with three targets to achieve within the next 10 years: To vaccinate 90 percent of all girls against human papillomavirus by the age of 15; to expand access to screening services for 70 percent of women; and to expand access to treatment for 90 percent of women with pre-cancerous lesions, and palliative care for 90 percent of women with invasive cancer.
However, the WHO chief said the pandemic has caused setbacks to progress towards these targets because of disruption to health services. He said, “The proportion of girls globally with access to HPV vaccines has fallen to 13 percent, from 15 percent before the pandemic. At the same time, there are encouraging signs of progress. In the past year, several more countries have introduced the HPV vaccine into national immunization schedules, including Cameroon, Cabo Verde, El Salvador, Mauritania, Qatar, Sao Tome and Principe, and Tuvalu. WHO has also prequalified a fourth HPV vaccine called Cecolin, produced by Innovax, which we expect will increase supply and decrease prices. We have also seen innovations like self-sampling, which offers women the option of being screened for cervical cancer without a pelvic exam."
Dr Tedros also announced the release of WHO’s evidence generation framework for artificial intelligence-based screening. However, he said, “We need to do much more. Today we are calling on all countries, all manufacturers of vaccines, tests and treatments, all partners and all civil society organizations to join us in our effort to make cervical cancer history."
Speaking at a press conference in Geneva today (17 Nov), WHO chief Dr Tedros Ghebreyesus said cervical cancer is the fourth most common cancer among women globally, “but it is almost completely preventable and, if diagnosed early enough, is one of the most successfully treatable cancers.” He said the disease claims the lives a woman every two minutes. He added, “Like COVID-19, we have the tools to prevent, detect, and treat this disease. But like COVID-19, cervical cancer is driven by inequitable access to those tools. 79 countries that account for two-thirds of the global burden of cervical cancer are yet to introduce HPV vaccines, because of high prices and inadequate supply."
Dr Tedros said, in low- and middle-income countries, the incidence of cervical cancer “is nearly twice as high, and the death rate is three times as high, as in high-income countries.” He said there are similar disparities among marginalized populations within many high-income countries.
A year ago today, WHO had launched a global strategy to eliminate cervical cancer, with three targets to achieve within the next 10 years: To vaccinate 90 percent of all girls against human papillomavirus by the age of 15; to expand access to screening services for 70 percent of women; and to expand access to treatment for 90 percent of women with pre-cancerous lesions, and palliative care for 90 percent of women with invasive cancer.
However, the WHO chief said the pandemic has caused setbacks to progress towards these targets because of disruption to health services. He said, “The proportion of girls globally with access to HPV vaccines has fallen to 13 percent, from 15 percent before the pandemic. At the same time, there are encouraging signs of progress. In the past year, several more countries have introduced the HPV vaccine into national immunization schedules, including Cameroon, Cabo Verde, El Salvador, Mauritania, Qatar, Sao Tome and Principe, and Tuvalu. WHO has also prequalified a fourth HPV vaccine called Cecolin, produced by Innovax, which we expect will increase supply and decrease prices. We have also seen innovations like self-sampling, which offers women the option of being screened for cervical cancer without a pelvic exam."
Dr Tedros also announced the release of WHO’s evidence generation framework for artificial intelligence-based screening. However, he said, “We need to do much more. Today we are calling on all countries, all manufacturers of vaccines, tests and treatments, all partners and all civil society organizations to join us in our effort to make cervical cancer history."
Category
Personal Subjects
Corporate Subjects
Source
Alternate Title
unifeed211117d